CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L.
Guerra B, et al.
Oncotarget. 2017 May 2;8(18):29679-29698. doi: 10.18632/oncotarget.11425.
Oncotarget. 2017.
PMID: 27557509
Free PMC article.